Parallel Advisors, LLC Selecta Biosciences Inc Transaction History

Parallel Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.67 - $1.35 $67 - $135	100 Added 100.0%	200 $0
Q1 2023 May 20, 2024	BUY	$1.15 - $1.89 $114 - $189	100 New	100 $0
Q1 2021 Apr 23, 2021	SELL	$2.92 - $5.07 $292 - $507	-100 Reduced 50.0%	100 $0
Q4 2020 Feb 02, 2021	BUY	$1.64 - $3.42 $328 - $684	200 New	200 $1,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.